NCT00519753View on ClinicalTrials.gov

Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav

PHASE4CompletedINTERVENTIONAL
Enrollment

522

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Glaucoma
Interventions
DRUG

Travoprost 0.004%/timolol maleate 0.5% fixed combination ophthalmic solution (DuoTrav)

One drop in study eye(s) once daily in the evening (at 8:00 PM) for 12 weeks

Trial Locations (1)

DE-55101

Mainz, Mainz

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00519753 - Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav | Biotech Hunter | Biotech Hunter